Latest Impairment News

Commonwealth Bank of Australia reported a 5% rise in net profit for the half-year ended December 2025, balancing lending growth with margin pressures and increased technology investment.

Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.

Computershare Limited reported a 5.4% increase in revenue to $1.58 billion for the half-year ended December 2025, driven by growth across its core businesses. However, profit after tax slipped 2.6%, weighed down by disposal costs and rising expenses related to the UK Mortgage Services sale.

G8 Education has announced a significant $350 million goodwill impairment for FY25, reflecting ongoing sector pressures. Despite this, the company maintains its EBIT guidance but suspends dividends and pauses its share buyback program.

Amotiv Limited reported a 3.3% revenue increase to $520.5 million for the half year ended December 2025, alongside a 39.4% jump in net profit, driven by new business wins and operational efficiencies despite margin pressures in key segments.

360 Capital Mortgage REIT (ASX – TCF) reported a robust HY26 with a 10.4% distribution yield and a $16.6 million capital raise, underscoring its disciplined growth and strong portfolio performance.

360 Capital Mortgage REIT reported a robust half-year performance with a 40.5% increase in gross assets and a targeted 10.4% distribution yield for FY26, underpinned by disciplined lending and solid capital raising.

Ainsworth Game Technology reveals a significant $43.1 million goodwill impairment tied to its North American operations, alongside other one-off losses, tempering its FY25 profit outlook.

Credit Corp Group posted a steady first half with 4% revenue growth and flat net profit, setting the stage for a robust second half driven by increased lending and debt buying investments.

Credit Corp delivers steady H1 FY26 results with robust US collections and record lending volumes, while pursuing a strategic acquisition to boost its consumer finance footprint.

Credit Corp Group Limited reported a steady half-year profit with a 4% revenue rise, driven by strong US collections and record lending volumes, while advancing its UK presence through a strategic acquisition.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.